The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients
Phase 1
Completed
- Conditions
- Hepatitis C
- Interventions
- Biological: Peginterferon lambda
- First Posted Date
- 2014-02-14
- Last Posted Date
- 2016-12-15
- Target Recruit Count
- 60
- Registration Number
- NCT02063607
- Locations
- 🇻🇳
The Military 108 Hospital, Hanoi, Vietnam
© Copyright 2025. All Rights Reserved by MedPath